Intuitive Surgical, Inc. vs Rivian Automotive, Inc. — how do they compare? Intuitive Surgical, Inc. trades at $423.96 (market cap $146.76B), while Rivian Automotive, Inc. trades at $13.96 (market cap $20.75B). The key difference: Intuitive Surgical, Inc. is far larger — about 7.1× Rivian Automotive, Inc.'s market cap, and Intuitive Surgical, Inc. is trading nearer its 52-week high, Rivian Automotive, Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Intuitive Surgical, Inc. for 84 Days and Rivian Automotive, Inc. for 61 Days on average.
| ISRG | RIVN | |
|---|---|---|
Market Cap | $146.76B | $20.75B |
Volume | 2,529,814 | 26,144,654 |
Sector | Health | Consumer Cyclical |
52-Week High | $592.85 | $22.45 |
52-Week Low | $332.02 | $12.50 |
Typical Hold Time | 84 Days | 61 Days |
Enterprise Value | $141.54B | $20.79B |
Signals from Pluang's Aura AI — not financial advice
Intuitive Surgical (ISRG) trades at $415.41, up 0.21% with a bullish technical outlook. The stock shows strong fundamentals with 2025 revenue of $10.06B and net income of $2.86B, maintaining consistent earnings beats. Valuation metrics remain elevated with a P/E of 47.64 and P/S of 13.54, reflecting premium pricing for the robotic surgery leader. Recent news highlights international expansion in India and Japan to offset China weakness, while da Vinci 5 upgrades and ASC market penetration drive growth.
ISRG presents a compelling growth story with dominant market position and expanding global footprint, though premium valuation requires sustained execution. Key risks include procedure growth moderation and competitive pressures. Analyst consensus remains strongly bullish with $480.78 price target representing 16% upside potential from current levels.
Rivian (RIVN) trades at $14.33, down 0.07% on the day, with a bearish technical signal from moving averages. The company reported record Q3 2026 deliveries of 19,248 vehicles, beating estimates, but maintained full-year guidance, causing mixed market reactions. Financially, revenue growth continues while losses narrow, with a net income margin of -54.95% in 2025. Analyst consensus is a Buy with a $16.89 price target, though cash burn remains a concern with negative operating cash flow.
Rivian's outlook hinges on scaling R2 production and advancing autonomy, offering growth potential, but high cash burn, competitive pressures, and execution risks pose significant challenges. The stock presents a speculative opportunity for investors betting on EV adoption and operational improvements, balanced by substantial financial and market volatility risks.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 7,000 da Vinci systems in hospitals worldwide, with more than 4,000 installations in the United States and a growing number in emerging markets.
Read more on ISRG →Rivian Automotive, Inc. is an automotive technology company. The Company designs and manufactures vans, trucks, and sports utility vehicles, as well as offers repair and maintenance services. Rivian Automotive serves customers in North America and the United Kingdom.
Read more on RIVN →